Results 21 to 30 of about 365,101 (202)

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma [PDF]

open access: yes, 2010
Background: The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure ...
Pinna, Antonio D.   +402 more
core   +4 more sources

Initial immunosuppression used.

open access: yes, 2022
Initial immunosuppression used.
Joshua Storrar (10682937)   +9 more
core   +1 more source

Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes

open access: yesCritical Care, 2020
Background Decreased monocytic (m)HLA-DR expression is the most studied biomarker of sepsis-induced immunosuppression. To date, little is known about the relationship between sepsis characteristics, such as the site of infection, causative pathogen, or ...
Guus P. Leijte   +8 more
doaj   +1 more source

Monocyte Trajectories Endotypes Are Associated With Worsening in Septic Patients

open access: yesFrontiers in Immunology, 2021
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The immune system plays a key role in sepsis onset and remains dysregulated over time in a heterogeneous manner.
Maxime Bodinier   +16 more
doaj   +1 more source

To be (immunosuppressive) or not to be [PDF]

open access: yesNature Reviews Cancer, 2019
Singhal et al. characterized tumour-infiltrating monocyte and macrophage lineage cells in patients with early stage lung cancer and found that, contrary to data in mouse models, the function of these cells might not be primarily immunosuppressive.
openaire   +2 more sources

A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients

open access: yesFrontiers in Immunology, 2022
Immune responses affiliated with COVID-19 severity have been characterized and associated with deleterious outcomes. These approaches were mainly based on research tools not usable in routine clinical practice at the bedside. We observed that a multiplex
Claire Tardiveau   +39 more
doaj   +1 more source

Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial

open access: yesCritical Care, 2017
Background Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we
Jonathan Plassais   +7 more
doaj   +1 more source

Early herpes and TTV DNAemia in septic shock patients: a pilot study

open access: yesIntensive Care Medicine Experimental, 2019
Background Septic shock patients exhibit an increased incidence of viral reactivation. Precise timing of such reactivation—as an early marker of immune suppression, or as a consequence of the later—is not known precisely.
François Mallet   +18 more
doaj   +1 more source

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy

open access: yesExploration of Immunology, 2022
Sepsis is a life-threatening condition caused by dysregulated host immune response to infection, leading to persistent inflammation followed by immunosuppression.
Dablu Lal Gupta   +4 more
doaj   +1 more source

T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19

open access: yesEBioMedicine, 2022
Summary: Background: In critically ill COVID-19 patients, the initial response to SARS-CoV-2 infection is characterized by major immune dysfunctions.
Fabienne Venet   +24 more
doaj   +1 more source

Home - About - Disclaimer - Privacy